There’s a miraculous new treatment for schizophrenia that could transform the way we treat mental illness. And then there are the terrible reasons why most medical professionals have never heard of it. (EARLY PSYCHOSIS TREATMENT)
When they began studying people who had developed symptoms only recently, they found that the changes to the prefrontal cortex and gray matter were far less pronounced. Patients were more sensitive to medication, which meant that the standard high doses created more debilitating side effects—and that low doses would be more than adequate to control hallucinations and delusions. Newly diagnosed patients also responded better to cognitive therapy to help them deal with irregular thoughts. Eventually, researchers homed in on a key variable: the duration of untreated psychosis, or D.U.P. They theorized that the shorter the interval between the first appearance of symptoms and when a person gets treatment, the greater the chance of some form of meaningful recovery.
READ THE FULL STORY HERE: